Herceptin Therapy For Breast Cancer
Herceptin (trastuzumab) is a chemotherapy infusion medication approved for metastatic breast cancer and as an adjuvant treatment for HER2-positive breast cancer. The drug is essentially a protein that targets and binds to the human epidermal growth factor receptor2 (HER2) protein to impede cancer cells from proliferating further. HER2 is an aggressive form of breast cancer that grows and spreads rapidly. About one in five women with breast cancer have HER2-positive breast cancer or protein human epidermal growth factor receptor2....